Mark Assmus

University of Calgary, Northwestern University

Papers

2

Total Citations

43

H-Index

2

About

Dr. Mark Assmus is a leading urologic surgeon and researcher whose work centers on advancing surgical treatments for benign prostatic hyperplasia (BPH). His primary research areas include minimally invasive surgical techniques, comparative outcomes of prostate procedures, and long-term durability of BPH interventions. Dr. Assmus is best known for his landmark 2022 study comparing holmium laser enucleation of the prostate (HoLEP) with open and robotic simple prostatectomy for large-gland BPH, which has garnered 36 citations and serves as a critical reference for surgeons selecting optimal approaches. His 2023 investigation into surgical re-treatment rates after prostatic urethral lift (PUL) revealed that approximately one in seven patients require additional surgery within five years—a finding that has reshaped clinical counseling and patient expectations. This work highlights the importance of long-term outcomes in shared decision-making. With a growing citation impact, Dr. Assmus continues to shape evidence-based urologic practice, offering invaluable insights for trainees and practitioners navigating the evolving landscape of BPH management.

Research Focus

Key Achievements

2
H-Index
2
Papers
43
Total Citations
22
Avg Citations/Paper
🏆 Most Cited Paper
An Outcomes Comparison Between Holmium Laser Enucleation of the Prostate, Open Simple Prostatectomy, and Robotic Simple Prostatectomy for Large Gland Benign Prostatic Hypertrophy
36 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 9
🏛 Institutions: University of Calgary, Northwestern University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago